{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:19:05Z","timestamp":1790813945125,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1002\/jps.23309","type":"journal-article","created":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T19:58:10Z","timestamp":1346529490000},"page":"4642-4652","source":"Crossref","is-referenced-by-count":43,"title":["Therapeutic Drug Monitoring in Interstitial Fluid: A Feasibility Study Using a Comprehensive Panel of Drugs"],"prefix":"10.1016","volume":"101","author":[{"given":"Tony K.L.","family":"Kiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary H.H.","family":"Ensom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs O.","family":"H\u00e4feli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.23309_bb0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2165\/00003088-199834040-00001","article-title":"Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes?","volume":"34","author":"Ensom","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.23309_bb0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00003088-199630030-00003","article-title":"Drug monitoring in nonconventional biological fluids and matrices","volume":"30","author":"Pichini","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.23309_bb0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/clinids\/3.1.45","article-title":"Pharmacokinetics of tissue penetration of antibiotics","volume":"3","author":"Bergan","year":"1981","journal-title":"Rev Infect Dis"},{"key":"10.1002\/jps.23309_bb0025","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.clinbiochem.2008.09.112","article-title":"Continuous glucose monitoring: A review of biochemical perspectives and clinical use in type 1 diabetes","volume":"42","author":"Girardin","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1002\/jps.23309_bb0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00134-005-0015-3","article-title":"Levels of vancomycin in the cerebral interstitial fluid after severe head injury","volume":"32","author":"Caricato","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1002\/jps.23309_bb0035","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1128\/AAC.40.12.2703","article-title":"Characterization of peripheral\u2010compartment kinetics of antibiotics by in vivo microdialysis in humans","volume":"40","author":"Muller","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.23309_bb0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.coph.2005.04.010","article-title":"Microdialysis for in vivo pharmacokinetic\/pharmacodynamic characterization of anti\u2010infective drugs","volume":"5","author":"Brunner","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1002\/jps.23309_bb0045","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1515\/CCLM.2011.727","article-title":"Comparison of vancomycin concentrations in blood and interstitial fluid: A possible model for less invasive therapeutic drug monitoring","volume":"49","author":"H\u00e4feli","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1002\/jps.23309_bb0050","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1592\/phco.29.11.1275","article-title":"Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health\u2010System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"29","author":"Rybak","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1002\/jps.23309_bb0055","first-page":"675","article-title":"Antimicrobial agents\u2014Part II. The aminoglycosides: Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin","volume":"52","author":"Brewer","year":"1977","journal-title":"Mayo Clin Proc"},{"key":"10.1002\/jps.23309_bb0060","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jps.2600830419","article-title":"Pharmacokinetics of gentamicin in rabbits pretreated with nonsteroidal anti\u2010inflammatory drugs: An interaction study","volume":"83","author":"Shivprakash","year":"1994","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23309_bb0065","first-page":"108","article-title":"Immunosuppressive agents in organ transplantation: Past, present, and future","volume":"20","author":"Hong","year":"2000","journal-title":"Semin Nephrol"},{"key":"10.1002\/jps.23309_bb0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0090-9556(25)08134-6","article-title":"The pharmacokinetics of cyclosporine. I. Single dose and constant rate infusion studies in the rabbit","volume":"13","author":"Awni","year":"1985","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.23309_bb0075","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00007691-199704000-00005","article-title":"Pharmacodynamic monitoring of mycophenolic acid in rabbit heterotopic heart transplant model","volume":"19","author":"Langman","year":"1997","journal-title":"Ther Drug Monit"},{"key":"10.1002\/jps.23309_bb0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3458.2003.tb00249.x","article-title":"Valproate: Past, present, and future","volume":"9","author":"Johannessen","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1002\/jps.23309_bb0085","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1528-1157.1978.tb05034.x","article-title":"Excretion of valproic acid into semen of rabbits and man","volume":"19","author":"Swanson","year":"1978","journal-title":"Epilepsia"},{"key":"10.1002\/jps.23309_bb0090","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0897190005280050","article-title":"Pharmacotherapy overview of seizure management in the adult emergency department","volume":"18","author":"Idrees","year":"2005","journal-title":"J Pharm Pract"},{"key":"10.1002\/jps.23309_bb0095","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1023\/A:1018957420197","article-title":"Phenobarbital disposition in adult and neonatal rabbits","volume":"11","author":"Yoo","year":"1994","journal-title":"Pharm Res"},{"key":"10.1002\/jps.23309_bb0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF03190421","article-title":"Pharmacokinetics of phenytoin following intravenous and intramuscular administration of fosphenytoin and phenytoin sodium in the rabbit","volume":"27","author":"Muchohi","year":"2002","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1002\/jps.23309_bb0105","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.1999.17.1.409","article-title":"Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin","volume":"17","author":"Go","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1002\/jps.23309_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1179\/joc.2004.16.Supplement-1.77","article-title":"Platinums: Extending their therapeutic spectrum","volume":"16","author":"Muggia","year":"2004","journal-title":"J Chemother"},{"key":"10.1002\/jps.23309_bb0115","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1167\/iovs.04-0228","article-title":"Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: Possible implication in the treatment of retinoblastoma","volume":"45","author":"Hayden","year":"2004","journal-title":"Invest Opthalmol Vis Sci"},{"key":"10.1002\/jps.23309_bb0120","first-page":"344","article-title":"Concentration change of chemotherapeutic agents in plasma and tissue after intraarterial and intravenous injection","volume":"24","author":"Zhang","year":"2002","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1002\/jps.23309_bb0125","first-page":"1245","article-title":"Diagnosis and management of rheumatoid arthritis","volume":"84","author":"Wasserman","year":"2011","journal-title":"Am Fam Physician"},{"key":"10.1002\/jps.23309_bb0130","first-page":"1","article-title":"Methotrexate: A detailed review on drug delivery and clinical aspects","volume":"18","author":"Khan","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1002\/jps.23309_bb0135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF01062208","article-title":"Pharmacokinetics of methotrexate and 7\u2010hydroxy\u2010methotrexate in rabbits after intravenous administration","volume":"11","author":"Chen","year":"1983","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1002\/jps.23309_bb0140","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1164\/rccm.200210-1142PP","article-title":"Theophylline: New perspectives for an old drug","volume":"167","author":"Barnes","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/jps.23309_bb0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/pulp.1996.0020","article-title":"Comparative pharmacokinetics of theophylline in rabbits and in humans with hyperlipidemia","volume":"9","author":"Wojcicki","year":"1996","journal-title":"Pulm Pharmacol"},{"key":"10.1002\/jps.23309_bb0150","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/MJT.0b013e3181c6c0d2","article-title":"Contemporary indications and therapeutic implications for digoxin use","volume":"18","author":"Mittal","year":"2011","journal-title":"Am J Ther"},{"key":"10.1002\/jps.23309_bb0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0928-0987(00)00096-8","article-title":"Pharmacokinetics of intravenously administered digoxin and histopathological picture in rabbits with experimental bile duct obstruction","volume":"11","author":"Wojcicki","year":"2000","journal-title":"Eur J Pharm Sci"},{"key":"10.1002\/jps.23309_bb0160","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/BF00295878","article-title":"Assessment of subcutaneous glucose concentration: Validation of the wick technique as a reference for implanted electrochemical sensors in normal and diabetic dogs","volume":"30","author":"Fischer","year":"1987","journal-title":"Diabetologia"},{"key":"10.1002\/jps.23309_bb0165","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/BF00172782","article-title":"Theophylline kinetics in peripheral tissues in vivo in humans","volume":"352","author":"Muller","year":"1995","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1002\/jps.23309_bb0170","first-page":"2982","article-title":"Interstitial methotrexate kinetics in primary breast cancer lesions","volume":"58","author":"Muller","year":"1998","journal-title":"Cancer Res"},{"key":"10.1002\/jps.23309_bb0175","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/193229680700100507","article-title":"Putative delays in interstitial fluid (ISF) glucose kinetics can be attributed to the glucose sensing systems used to measure them rather than the delay in ISF glucose itself","volume":"1","author":"Voskanyan","year":"2007","journal-title":"J Diabetes Sci Technol"},{"key":"10.1002\/jps.23309_bb0180","first-page":"256","article-title":"Distribution of valproate to subdural cerebrospinal fluid, subcutaneous extracellular fluid, and plasma in humans: A microdialysis study","volume":"42","author":"Lindberger","year":"2001","journal-title":"Epilepsia"},{"key":"10.1002\/jps.23309_bb0185","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/AAC.12.5.606","article-title":"Gentamicin intravenous infusion rate: Effect on interstitial fluid concentration","volume":"12","author":"Kozak","year":"1977","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1002\/jps.23309_bb0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1359-4117.2002.01019.x","article-title":"Use of microdialysis to study platinum anticancer agent pharmacokinetics in preclinical models","volume":"2","author":"Johansen","year":"2002","journal-title":"J Exp Ther Oncol"},{"key":"10.1002\/jps.23309_bb0195","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/bjc.1996.164","article-title":"Measurement of extracellular fluid carboplatin kinetics in melanoma metastases with microdialysis","volume":"73","author":"Blochl\u2010Daum","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1002\/jps.23309_bb0200","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00280-009-1085-7","article-title":"Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates","volume":"65","author":"Jacobs","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1002\/jps.23309_bb0205","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/02688690600999786","article-title":"Free phenytoin concentration measurement in brain extracellular fluid: A pilot study","volume":"20","author":"Tisdall","year":"2006","journal-title":"Br J Neurosurg"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491531296X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235491531296X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T17:57:16Z","timestamp":1744048636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235491531296X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S002235491531296X"],"URL":"https:\/\/doi.org\/10.1002\/jps.23309","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}